CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (âAdaptHealthâ or the âCompanyâ), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the second quarter ended June 30, 2025. Second Quarter Results and Highlights All comparisons are to the quarter ended June 30, 2024 unless otherwise stated. Net revenue was $800.4 million compared to $806.
Related Questions
Did the company announce any new product launches, partnerships, or acquisitions that could impact future growth?
What were the gross margin and operating margin trends compared to the same quarter last year?
What are the key drivers behind any changes in the company's debt levels or credit facility usage?
What was the year-over-year change in net revenue and what drove the $5.6 million decrease?
Are there any regulatory or reimbursement changes affecting the companyâs outlook?
How did the earnings per share (EPS) for Q2 2025 compare to market expectations and the prior year?
How did operating expenses and SG&A costs change quarterâoverâquarter?
What was the cash flow from operations and did it meet analysts' expectations?
Did the company issue any updates to its capital allocation plan, including capâex, share buybacks, or dividend changes?
Did the company provide any guidance or outlook for Q3 2025 and the full year 2025?
How does AdaptHealth's Q2 performance compare to its main competitors in the home medical equipment sector?
Does the -10 sentiment score translate into increased shortâinterest or a shift in institutional ownership?
What is the current valuation (P/E, EV/EBITDA) relative to peers and how might the Q2 results impact the valuation multiples?
Are there any notable changes in the patientâcentered care and homeâhealth market that could affect the company's longâterm prospects?
What is the current guidance on revenue growth for the next 12â18 months and does the market anticipate it?